UK pharma sector braced for regulatory shake-up after Brexit

UK pharma sector braced for regulatory shake-up after Brexit

The UK’s pharmaceutical regulator would lose influence over the European Medicines Agency (EMA) if Britons vote to leave the EU in a June referendum. As a result, it could well consider aligning itself with its US equivalent, sector advisors have told EurActiv.com.